Skip to the content
Company
Business
Products
PR
Company
Business
Products
PR
Public Relations
Press Release (Korean)
Mbiometherapeutics Inc., Business Agreement Through 'Korea-Vietnam Business Partnering Project'
Mbiometherapeutics Inc. signed a business agreement with Vietnamese companies through '2023 Korea-Vietnam Business Partnering Project.'
2023.03.31
Yogurt that Cures Cancer?... Mbiometherapeutics Inc. Makes 'Impossible Treatment' with Harmless Microorganisms
[Start-UP Story] Kang Se Chan, CEO of Mbiometherapeutics Inc., said, "We are entering the preclinical examination of new microbial drugs... My goal is to treat cancer."
2022.12.12
"Which Startup Will Lead The Future Food Technology Industry?" Lotte Ventures Selected Five Companies for Future Food II Project
Lotte Group affiliates offer up to 500 million KRW in investment
One on one mentoring, follow-up support, shared office support, etc.
Looked for startups from four areas: Future Food, Medical Food, Packaging, and Alternative Food Ingredients
2022.07.29
Mbiometherapeutics Ic., "All Microbial-Related Source Technology Are In Place."
Mbiometherapeutics Inc.(CEO Kang Se Chan)'s vision is to improve the pharmaceutical ingredient market, which is dependent on imports, by securing biological resource sovereignty of ingredients. The company's goal is to "create high-value-added profits through strengthening global competitiveness" and "contribute to society through job creation."
2021.12.08
Mbiometherapeutics Inc., Nominated In '2021 Innovation Company' Bio-Innovation Awards
Kang Se Chan, CEO of Mbiometherapeutics Inc., is taking a commemorative photo after receiving the 'Bio-Innovation Grand Prize' in the microbial treatment category at the '2021 Innovation Company' Bio-Innovation Awards.
2021.12.08
[Interview with Members] Mbiometherapeutics Inc.: CEO Kang Se Chan
Mbiometherapeutics, the company that studies and utilizes unknown microorganisms to make treatment!
2021.09.29
Company Name: Mbiometherapeutics 엠바이옴쎄라퓨틱스
Business Registration Number: 776-86-01702
Address: 5F-2, Pangyo-ro 289beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-do, Republic of Korea (13488)
Copyright ⓒ MBIOMETHERAPEUTICS
Company
Business
Products
PR
Company
Business
Products
PR